Additionally, decreased tNAA has been demonstrated in multiple neurodegenerative diseases (Adanyeguh et al., 2015), including SCA3 (Miranda et al., 2022; Chandrasekaran et al., 2022), and is classified as a marker of neuronal and axonal degeneration. The gene discussed is ATXN3; the disease is neurodegenerative disease.